Skip to content

Engineering carboxyl methyltransferase for high-efficiency biosynthesis of methyl salicylate in Escherichia coli.

Sep 2026 · Bioresource Technology · pp. 135886 · 0 citations · 41 references
Medicine

Abstract

Methyl salicylate (MeSA) is a volatile methylated aromatic ester widely used in agriculture, food, and pharmaceuticals. Microbial biosynthesis offers a sustainable alternative to plant extraction and petrochemical synthesis; however, efficient MeSA production remains limited by the low catalytic efficiency of carboxyl methyltransferases, insufficient intracellular supply of S-adenosylmethionine (SAM), and severe product volatilization during fermentation. In this study, we systematically screened salicylate carboxymethyltransferase and identified CbSAMT as a relatively efficient catalyst for salicylic acid (SA). To further improve catalytic performance, we engineered CbSAMT through fusion-protein design. Remarkably, the catalytic efficiency of 7 × His-CbSAMT was 12-fold higher than that of the wild-type. Molecular dynamics simulations and computational analyses revealed that the polyhistidine tag reshaped the catalytic microenvironment by remodeling the hydrogen-bonding network and reducing the distance between SA and key substrate-positioning residues, thereby enhancing substrate binding and catalytic turnover. To further enhance MeSA biosynthesis, we reinforced intracellular SAM regeneration and established an in situ two-phase fermentation system using n-dodecane as the extractant to alleviate product volatilization. Finally, fed-batch fermentation achieved a MeSA titer of 5.12 g/L, representing the highest production level reported to date. Collectively, this study highlights the potential of polyhistidine tags in enzyme engineering and provides an efficient platform for the biosynthesis of volatile methylated natural products.

View source

Similar papers

Sep 2026

Efficient Production of Vanillyl Alcohol in Escherichia coli via Protein and Pathway Engineering

Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineer...

Jin-Yi Li, Yong Du, Jia Wang et al. · 0 citations
Sep 2026

Rational design of heptaprenyl diphosphate synthase and metabolic optimization drive biosynthesis of menaquinone-7 by Escherichia coli.

Menaquinone-7 (MK-7) is a fat-soluble vitamin with important nutritional and pharmaceutical applications. However, microbial biosynthesis of MK-7 is limited by low catalytic efficiency of key enzymes, insufficient precursor supply, and imbalanced availability of nicotinamide adenine dinucleotide phosphate (NADPH). In t...

Zi-Hao Li, Kang-Jie Xu, Yi-Yi Chen et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.